Tag Archives: voyager therapeutics

February, 2015

  • 11 February

    Genzyme Enters Gene Therapy Deal with Voyager

    Sanofi’s subsidiary Genzyme is collaborating with gene therapy company Voyager Therapeutics for gene therapies for severe central nervous system (CNS) disorders. The companies announced today that they have entered into a major strategic collaboration to discover, develop and commercialize novel gene therapies for CNS disorders, leveraging Genzyme’s leadership in adeno-associated …